It Takes Guts: Psychedelic Treatment Approaches to Autoimmune Disorders

To date, much of the research conducted using psychedelics has focused on their potential for treating a wide range of mental disorders, an area where these compounds have shown significant promise. The interconnections between mental disorder and biochemical or physiological dysfunction are increasingly receiving attention, with research showing links between mood disorders and autoimmune diseases and mood disorders and the gut microbiome. Given this overlap, could psychedelics be used to treat automimmune diseases, and if so, what are the shared pathways and mechanisms of action involved?

For further exploration of these questions, see this article from the Psychedelic Science Review.

Previous
Previous

The default network of the human brain is associated with perceived social isolation.

Next
Next

Psychedelics re-engineered for potential use in the clinic.